Smart Money Ratings For 20 Most Undervalued Stocks

Page 6 of 18

13. IQVIA Holdings Inc. (NYSE:IQV)

Insider Transaction: 0.09%

Upside Potential: 36.74%

Forward P/E: 11.42

IQVIA Holdings Inc. (NYSE:IQV) is a leading global provider of advanced analytics and technology solutions. The focus of the company is heavily laid on clinical research services to the life sciences industry. The North Carolina-based company is a merger of IMS Health and Quintiles. The company delivers real-world evidence, trial design, and commercial outsourcing solutions. Against some tough competitors like Syneos Health and ICON plc, IQVIA Holdings Inc. (NYSE:IQV) gains its competitive edge by leveraging its proprietary platforms and AI integration. Alongside the pharmaceutical R&D expenditure, the company’s performance is also influenced by healthcare digitization trends.

Currently positioned 11.86% above its 52-week low, the company has made a moderate recovery in the market. IQVIA Holdings Inc. (NYSE:IQV)’s total revenue for the first quarter of 2025 exceeded the guidance, despite the market environment headwinds, including delayed responses from customers regarding new programs. The Technology and Analytics Solutions (TAS) segment, however, shows robust growth with revenue reaching a 6.4% increase. The company’s backlog registers a record high value of $31.5 billion, thus providing a positive outlook for 2025.

The low P/E ratio of 11.42 makes it one of the most undervalued stocks on our list. With only a 0.09% uptick, the insider activity further hints at minimal internal engagement. Hedge fund presence in stocks is strong, with 51 funds maintaining their holding positions, as per Insider Monkey’s Q4 2024 database. The upside potential of 36.74% gives attractiveness to the company and gains the interest of investors looking for undervalued stocks with notable growth potential.

Page 6 of 18